Thank you for participating as a China Conference: Southeast Asia (CCSEA) delegate, scheduled for February 18-19, 2020 in Manila, Philippines. We would like to share updates about our event with you.

We have been carefully monitoring the spread of the Coronavirus, the recommendations by the World Health Organization, as well as health and international travel advisories. In the interest of your safety, we are postponing the event. We will be in touch shortly with a new conference date.

We appreciate your patience and sincerely apologise for any inconvenience this may have caused. We look forward to having you join our conference later this year.

Thank you very much.


Dr. Mary Pan

Chinese American scientist; Chief Operating Officer, Health Decisions, USA

About me

Mary Pan 潘英君 is a Chinese American scientist and the Chief Operating Officer of Health Decisions, a 30-year-old biotechnology and diagnostics service provider in R&D with a focus on women’s health.   Gunn has a PhD in Psychology, MBA from Instituto Empresa and Brown University, LLM in Medical Ethics and Law from the University of Edinburgh, BA in Psychology, BA in Economics, and master’s in International Relations from Freie Universität Berlin.

Pan is an executive-level scientist with 25 years of experience including as COO and GM of private and public biotechnology, medical technology, and CRO companies, overseeing up to 38 countries, 4200 employees, and a $1.6 Billion portfolio in pharmaceuticals (Pfizer), biotechnology (Crucell), medical devices/diagnostics (Becton Dickinson), and Clinical Research Organizations (ICON Plc).  Therapeutic areas of expertise include women's health, oncology, autoimmune disease, neurology, vaccines/pandemic planning, and diagnostics.  Her career experience is in building and operating companies, fundraising, increasing sales/productivity, and turning around difficult situations through in-depth understanding of drug/device development and their commercialization, as well as global business expertise, having been based out of Europe (UK, Germany, Switzerland), Asia (China, Singapore), and the USA.  

Pan serves on the board of a startup cell therapy company, SpotArt Foundation, is an industrial advisor to private equity, and was elected to the Advisory Board of University Planning for Brown University.  She was also a founder of the first medical device trade association based out of Asia (APACMed).  Gunn served as the President of Alumni for University of Edinburgh and Brown University, where she was a President’s Scholar and an Eve and Simon Colin Foundation Scholar.